For example, a simultaneously increased BAL fluid level of CCL18 and TGF-β1 secreting CCR6+ CD4+ T-cells would raise clinical suspicion of fibrosing sarcoidosis, and the clinician could consider prescribing anti-fibrotic agents to minimize the damage of future fibrotic scarring. This evidence concerns the gene TGFB1 and sarcoidosis.